The Korean journal of internal medicine

  • 제27권4호
  • /
  • Pages.394-396
  • /
  • 2012
  • /
  • 1226-3303(pISSN)
  • /
  • 2005-6648(eISSN)
대한내과학회 (The Korean Association of Internal Medicine)
권호 표지
DOI QR코드

DOI QR Code

Treatment of Hepatitis B Virus-Associated Membranous Nephropathy: Lamivudine Era versus Post-Lamivudine Era

  • Moon, Ju-Young (Division of Nephrology, Department of Internal Medicine, Kyung Hee University Hospital at Gangdong) ;
  • Lee, Sang Ho (Division of Nephrology, Department of Internal Medicine, Kyung Hee University Hospital at Gangdong)
  • 발행 : 2012.12.01
⟨ 이전 논문 다음 논문 ⟩

초록

키워드

참고문헌

  1. Bhimma R, Coovadia HM. Hepatitis B virus-associated nephropathy. Am J Nephrol 2004;24:198-211. https://doi.org/10.1159/000077065
  2. Liao MT, Chang MH, Lin FG, Tsai IJ, Chang YW, Tsau YK. Universal hepatitis B vaccination reduces childhood hepatitis B virus-associated membranous nephropathy. Pediatrics 2011;128:e600-e604.
  3. Lai KN, Li PK, Lui SF, et al. Membranous nephropathy related to hepatitis B virus in adults. N Engl J Med 1991;324:1457-1463. https://doi.org/10.1056/NEJM199105233242103
  4. Yi Z, Jie YW, Nan Z. The efficacy of anti-viral therapy on hepatitis B virus-associated glomerulonephritis: a systematic review and meta-analysis. Ann Hepatol 2011;10:165-173.
  5. Zheng XY, Wei RB, Tang L, Li P, Zheng XD. Meta-analysis of combined therapy for adult hepatitis B virus-associated glomerulonephritis. World J Gastroenterol 2012;18:821-832. https://doi.org/10.3748/wjg.v18.i8.821
  6. Sun IO, Hong YA, Park HS, et al. Experience of anti-viral therapy in hepatitis B-associated membranous nephropathy, including lamivudine-resistant strains. Korean J Intern Med 2012;27:411-416. https://doi.org/10.3904/kjim.2012.27.4.411
  7. Chang TT, Gish RG, de Man R, et al. A comparison of entecavir and lamivudine for HBeAg-positive chronic hepatitis B. N Engl J Med 2006;354:1001-1010. https://doi.org/10.1056/NEJMoa051285
  8. Ebata S, Hashimoto S, Suzuki A, et al. A case of adefovir-induced membranous nephropathy related to hepatitis B caused by lamivudine-resistant virus after liver transplant due to Byler's disease. Clin Exp Nephrol 2012;16:805-810. https://doi.org/10.1007/s10157-012-0680-9
  9. Lai KN, Tam JS, Lin HJ, Lai FM. The therapeutic dilemma of the usage of corticosteroid in patients with membranous nephropathy and persistent hepatitis B virus surface antigenaemia. Nephron 1990;54:12-17. https://doi.org/10.1159/000185802
  10. Shin SK, Ryu DR, Hwang JH, et al. Comparison between lamivudine alone and lamivudine and steroid combination in treatment of nephrotic syndrome associated with hepatitis B. Korean J Nephrol 1999;18:550-559.

피인용 문헌

  1. A higher frequency of IL‐10‐producing B cells in Hepatitis B virus‐associated membranous nephropathy vol.43, pp.4, 2016, https://doi.org/10.1111/1440-1681.12552
  2. Primary Membranous Glomerulonephritis: The Role of Serum and Urine Biomarkers in Patient Management vol.7, pp.4, 2012, https://doi.org/10.3390/biomedicines7040086